Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00895752 · ClinicalTrials.gov registry record · Phase 4
Riluzole in Fragile X Syndrome
A Phase 4 study, sponsored by Indiana University.
- Completed
- Registry status
- Phase 4
- Development phase
- 6
- Enrollment target
NCT00895752 is a Phase 4 study that has completed, run by Indiana University. The registered enrollment target is 6 participants.
The verdict
NCT00895752, a Phase 4 study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the effectiveness and tolerability of riluzole in adults with Fragile X Syndrome.
Interventions
- DRUG Riluzole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2009-04 |
| Est. Completion | 2010-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00895752
The ClinicalTrials.gov registry entry for NCT00895752 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Riluzole is the first listed.
NCT00895752 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00895752 about?
NCT00895752 is a clinical study titled "Riluzole in Fragile X Syndrome". The purpose of this study is to investigate the effectiveness and tolerability of riluzole in adults with Fragile X Syndrome.
What is the current status of trial NCT00895752?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 6 participants. The study started on 2009-04. Estimated completion is 2010-07.
What interventions are being tested in trial NCT00895752?
The interventions under investigation include: Riluzole (DRUG).
Who is sponsoring clinical trial NCT00895752?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.